Comparison

G280-9 European Partner

Item no. HY-P1794-100mg
Manufacturer MedChem Express
CASRN 156761-76-1
Amount 100 mg
Quantity options 100 mg 10 mg 1 ea 1 mg 5 mg
Category
Type Peptides
Specific against other
Purity 99.23
Citations [1]Pass HA, et al. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. Cancer J Sci Am. 1998 Sep-Oct;4(5):316-23.
Smiles O=C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N1[C@@H](CCC1)C(NCC(N2[C@@H](CCC2)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC3=CC=C(C=C3)O)N
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Product Description
G280-9 is a 9 amino acid native epitope peptide. G280-9 is a relevant target expressed on melanoma.
StorageTemperature
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
946.05
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
H2O : 50 mg/mL (ultrasonic)
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close